+44 115 974 9000
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world
We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Vanessa Zann will be and presenting at at the CRS Drug Delivery Australia 2019 from 18 Nov.— Quotient Sciences (@Quotient_Sci) November 15, 2019
Vanessa's keynote ‘Using real-time adaptive manufacturing and clinical testing to optimize modified release formulations’, 18th November at 12pm (Brisbane, QLD). https://t.co/hZuNrwjkno pic.twitter.com/JJHvJcOI1n
BREAKING: Tufts CSDD Demonstrates Multi-Million Dollar Benefits of Translational Pharmaceutics®. For more information and to get a copy of the white paper visit: https://t.co/xoLGW8vGD4— Quotient Sciences (@Quotient_Sci) October 30, 2019
#drugdevelopment #tufts #translationalpharmaceutics #formulation #manufacturing #gmp pic.twitter.com/bSMqAzTljF